Pathogenesis of herpetic stromal keratitis in CCR5- and/or CXCR3-deficient mice

Current Eye Research

Volumn 33, Issue 9, 2008, Pages 736-749

  Komatsu, Keiko ^a   Miyazaki, Dai ^a   Morohoshi, Kei ^a   Kuo, Chuan Hui ^a   Kakimaru Hasegawa, Akiko ^a   Komatsu, Naoki ^a   Namba, Sachiko ^a   Haino, Makoto ^b   Matsushima, Kouji ^b   Inoue, Yoshitsugu ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

CCR5; CXCR3; Double deficient mouse; Herpes simplex virus; Herpetic stromal keratitis

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMOTAXIS; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; EYE; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; IMMUNOPATHOGENESIS; KNOCKOUT MOUSE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RIBONUCLEASE PROTECTION ASSAY; TRIGEMINUS GANGLION; VIRUS TITRATION;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CERCOPITHECUS AETHIOPS; CHEMOKINE CCL3; CHEMOKINE CCL4; CHEMOKINE CXCL11; CORNEAL STROMA; DNA, VIRAL; GENE DOSAGE; HERPESVIRUS 1, HUMAN; IMMUNOENZYME TECHNIQUES; KERATITIS, HERPETIC; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; RECEPTORS, CCR5; RECEPTORS, CXCR3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRIGEMINAL GANGLION; VERO CELLS;

EID: 51949096641     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680802344716     Document Type: Article

References (46)

1. Kumaraguru U, Davis I, Rouse BT. Chemokines and ocular pathology caused by corneal infection with herpes simplex virus. J Neurovirol. 1999;5:42-47.
2. Hendricks RL, Janowicz M, Tumpey TM. Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas. J Immunol. 1992;148:2522-2529.
3. Lewkowicz-Moss SJ, Shimeld C, Lipworth K, et al. Quantitative studies on Langerhans cells in mouse corneal epithelium following infection with herpes simplex virus. Exp Eye Res. 1987;45:127-140.
4. Miller JK, Laycock KA, Nash MM, Pepose JS. Corneal Langerhans cell dynamics after herpes simplex virus reactivation. Invest Ophthalmol Vis Sci. 1993;34:2282-2290.
5. Thomas J, Rouse BT. Immunopathogenesis of herpetic ocular disease. Immunol Res. 1997;16:375-386.
6. Thomas J, Gangappa S, Kanangat S, Rouse BT. On the essential involvement of neutrophils in the immunopathologic disease: Herpetic stromal keratitis. J Immunol. 1997;158:1383-1391.
7. Deshpande SP, Zheng M, Lee S, Rouse BT. Mechanisms of pathogenesis in herpetic immunoinflammatory ocular lesions. Vet Microbiol. 2002;86:17-26.
8. Doymaz MZ, Rouse BT. Herpetic stromal keratitis: An immunopathologic disease mediated by CD4+ T lymphocytes. Invest Ophthalmol Vis Sci. 1992;33:2165-2173.
9. Biswas PS, Rouse BT. Early events in HSV keratitis Setting the stage for a blinding disease. Microbes Infect. 2005;7:799-810.
10. Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136:2348-2357.
11. Del Prete GF, De Carli M, Mastromauro C, et al. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest. 1991;88:346-350.
12. Salgame P, Abrams JS, Clayberger C, et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science, 1991;254:279-282.
13. Street NE, Schumacher JH, Fong TA, et al. Heterogeneity of mouse helper T cells. Evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. J Immunol. 1990;144:1629-1639.
14. Suzuki N, Nakajima A, Yoshino S, et al. Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis. Int Immunol. 1999;11:553-559.
15. Qin S, Rottman JB, Myers P, et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest. 1998;101:746-754.
16. Yamamoto J, Adachi Y, Onoue Y, et al. CD30 expression on circulating memory CD4+ T cells as a Th2-dominated situation in patients with atopic dermatitis. Allergy. 2000;55:1011-1018.
17. Yoshie O, Imai T, Nomiyama H. Chemokines in immunity. Adv Immunol. 2001;78:57-110.
18. Zlotnik A, Yoshie O. Chemokines: A new classification system and their role in immunity. Immunity. 2000;12:121-127.
19. O'Garra A, McEvoy LM, Zlotnik A. T-cell subsets: Chemokine receptors guide the way. Curr Biol. 1998;8:R646-649.
20. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med. 1998;187:875-883.
21. Bonecchi R, Bianchi G, Bordignon PP, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med. 1998;187:129-134.
22. Imai T, Nagira M, Takagi S, et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol. 1999;11:81-88.
23. Bleul CC, Wu L, Hoxie JA, et al. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA. 1997;94:1925-1930.
24. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature. 1990;347:669-671.
25. Taub DD, Conlon K, Lloyd AR, et al. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science. 1993;260:355-358.
26. Flier J, Boorsma DM, van Beek PJ, et al. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol. 2001;194:398-405.
27. Heiligenhaus A, Bauer D, Zheng M, et al. CD4+ T-cell type 1 and type 2 cytokines in the HSV-1 infected cornea. Graefes Arch Clin Exp Ophthalmol. 1999;237:399-406.
28. Su YH, Yan XT, Oakes JE, Lausch RN. Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection. J Virol. 1996;70:1277-1281.
29. Tumpey TM, Cheng H, Cook DN, et al. Absence of macrophage inflammatory protein-1alpha prevents the development of blinding herpes stromal keratitis. J Virol. 1998;72:3705-3710.
30. Cook WJ, Kramer MF, Walker RM, et al. Persistent expression of chemokine and chemokine receptor RNAs at primary and latent sites of herpes simplex virus 1 infection. Virol J. 2004;1:5.
31. Shirane J, Nakayama T, Nagakubo D, et al. Corneal epithelial cells and stromal keratocytes efficently produce CC chemokine-ligand 20 (CCL20) and attract cells expressing its receptor CCR6 in mouse herpetic stromal keratitis. Curr Eye Res. 2004;28:297-306.
32. Spear PG, Roizman B. Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpes virion. J Virol. 1972;9:143-159.
33. Newell CK, Martin S, Sendele D, et al. Herpes simplex virus-induced stromal keratitis: Role of T-lymphocyte subsets in immunopathology. J Virol. 1989;63:769-775.
34. Miyazaki D, Inoue Y, Yao YF, et al. T-cell-mediated immune responses in alloepithelial rejection after murine keratoepithelioplasty. Invest Ophthalmol Vis Sci. 1999;40:2590-2597.
35. Shadidi KR, Thompson KM, Henriksen JE, et al. Association of antigen specificity and migratory capacity of memory T cells in rheumatoid arthritis. Scand J Immunol. 2002;55:274-283.
36. Gao W, Faia KL, Csizmadia V, et al. Beneficial effects of targeting CCR5 in allograft recipients. Transplantation. 2001;72:1199-1205.
37. Takeuchi A, Usui Y, Takeuchi M, et al. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response. Invest Ophthalmol Vis Sci. 2005;46:3753-3760.
38. Wickham S, Lu B, Ash J, Carr DJ. Chemokine receptor deficiency is associated with increased chemokine expression in the peripheral and central nervous systems and increased resistance to herpetic encephalitis. J Neuroimmunol. 2005;162:51-59.
39. Carr DJ, Ash J, Lane TE, Kuziel WA. Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1. J Gen Virol. 2006;87:489-499.
40. Lundberg P, Cantin E. A potential role for CXCR3 chemokines in the response to ocular HSV infection. Curr Eye Res. 2003;26:137-150.
41. Molesworth-Kenyon S, Mates A, Yin R, et al. CXCR3, IP-10, and Mig are required for CD4+ T cell recruitment during the DTH response to HSV-1 yet are independent of the mechanism for viral clearance. Virology. 2005;333:1-9.
42. Sozzani S, Allavena P, Vecchi A, Mantovani A. The role of chemokines in the regulation of dendritic cell trafficking. J Leukoc Biol. 1999;66:1-9.
43. von Andrian UH, Mackay CR. T-cell function and migration. Two sides of the same coin. N Engl J Med. 2000;343:1020-1034.
44. Jones D, Benjamin RJ, Shahsafaei A, Dorfman DM. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia. Blood. 2000;95:627-632.
45. Devalaraja MN, Richmond A. Multiple chemotactic factors: Fine control or redundancy? Trends Pharmacol Sci. 1999;20:151-156.
46. Tomoyuki I, Yoshitsugu I, Takako N, et al. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis. Invest Ophthalmol Vis Sci. 2000;41:4209-4215.